This past summer the NDB and the Arthritis Foundation teamed up to create the new research study called AIR (Arthritis Internet Registry). Patients in AIR fill out questionnaires every 6 months along with everyone in the NDB, but in addition they’re being asked to donate their blood. While we continue to see how all forms of arthritis are affected by different treatments, we’re hoping to find out if there are clues in the blood that would tell physicians which drugs would work best the first time. We’ve just started this project along with researchers at Harvard Medical School and Quest Diagnostics. As we get more participants and questionnaires, expect to hear more about ways “biomarkers” in our blood can help.